Search results
11 sie 2023 · RPF can lead to venous or arterial occlusion of large abdominal blood vessels and hydronephrosis from ureteral obstruction. Patients may require medical therapy for the RPF and endovascular, urological, or surgical treatment for management of complications.
- Alessandra Palmisano, Md, PhD
UpToDate, electronic clinical resource tool for physicians...
- References
Untreated patients may develop severe complications...
- Alessandra Palmisano, Md, PhD
12 mar 2020 · Treatment for idiopathic retroperitoneal fibrosis consists of meticulous glucocorticoid therapy based on that for immunoglobulin G4-related disease, which is expected to be highly effective. Ureteral obstruction is usually managed with conservative procedures, such as ureteral stenting or percutaneous nephrostomy.
6 paź 2020 · The prognosis for retroperitoneal fibrosis is generally excellent with appropriate treatment, particularly as IgG4-related disease often responds well to glucocorticoid therapy. Without medical or surgical intervention, progressive ureteral obstruction is likely, leading to renal failure. [1]
11 mar 2021 · The goals of treatment are to remove the blockage, repair the affected ureter, and prevent it from happening again. For many people, treatment requires both medication and internal...
10 lut 2021 · Idiopathic RPF is a rare disease that usually has a sub-acute onset. An early diagnosis is mandatory to avoid the development of chronic obstructive nephropathy. The therapeutic management is both surgical, to relieve the obstruction, and pharmaceutical, to induce and maintain remission of inflammation.
If positive, treatment for a patient with RPF can be targeted to the underlying immune problem. In other patients inflammatory or degenerative conditions of blood vessels (such as Primary Vasculitis or atherosclerosis respectively) can be a cause, or simply make matters worse.
12 maj 2024 · Retroperitoneal fibrosis (RPF) is a fibroinflammatory disease in which patients may suffer obstructive uropathy (OU). The optimum treatment strategy for RPF with secondary OU is currently unclear, and the aim of this literature review is to assess the methods used to treat this patient cohort.
